Skip to main content
Clinical Trials/NCT05501132
NCT05501132
Completed
Phase 1

Efficacy of Transcranial Direct Current Stimulation (tDCS) in Symptoms, Quality of Life, Cognitive Deficits and Brain Physiology of Patients With Obsessive-compulsive Disorder

The National Brain Mapping Laboratory (NBML)1 site in 1 country42 target enrollmentAugust 1, 2020

Overview

Phase
Phase 1
Intervention
transcranial direct current stimulation
Conditions
Obsessive-Compulsive Symptom
Sponsor
The National Brain Mapping Laboratory (NBML)
Enrollment
42
Locations
1
Primary Endpoint
Beck Anxiety Questionnaire (BAI)
Status
Completed
Last Updated
last month

Overview

Brief Summary

This is a randomized, double-blind, parallel-group, sham-controlled trial that aims to investigate the effectiveness of transcranial direct current stimulation (TDCS) on improving symptoms, quality of life, depression, and cognitive functions in 39 patients with obsessive-compulsive disorder (OCD) that are randomized in 3 experimental groups.

Registry
clinicaltrials.gov
Start Date
August 1, 2020
End Date
February 25, 2022
Last Updated
last month
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
The National Brain Mapping Laboratory (NBML)
Responsible Party
Principal Investigator
Principal Investigator

Mohammad Ali Salehinejad

Principal Investigator

Technical University of Dortmund

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Obsessive-compulsive Disorder by a psychiatrist and DSM-5-based behavioral checklist
  • being 18-50 years old
  • providing written informed consent
  • If female, negative urine pregnancy test
  • stable medication regime especially the classical neuroleptics and all CNS-activating medications, if taken, 4-6 weeks before the experiment and during the experiment

Exclusion Criteria

  • pregnancy
  • alcohol or substance dependence
  • history of seizure
  • history of neurological disorder
  • history of head injury
  • presence of ferromagnetic objects in the body that are contraindicated for brain stimulation of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments) or fear of enclosed spaces.

Arms & Interventions

Control group

In the placebo group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of sham electrical stimulation on 5 consecutive days with two sessions per day.

Intervention: transcranial direct current stimulation

tDCS group 1

In the first experimental group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of 1 mA electrical stimulation on 5 consecutive days with two sessions per day.

Intervention: transcranial direct current stimulation

tDCS group 2

In the second experimental group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of 2 mA electrical stimulation on 5 consecutive days with two sessions per day.

Intervention: transcranial direct current stimulation

Outcomes

Primary Outcomes

Beck Anxiety Questionnaire (BAI)

Time Frame: up to 1 month after the intervention

Score in the Beck Anxiety Questionnaire (BAI). The BAI scores are classified as minimal anxiety (0 to 7), mild anxiety (8 to 15), moderate anxiety (16 to 25), and severe anxiety (30 to 63).

Yale-Brown Obsessive-Compulsive (Y-BOCS) rating scale

Time Frame: up to 1 month after the intervention

Score in the Yale-Brown Obsessive-Compulsive (Y-BOCS). Total scores on the measure range from 0 to 40, with a score of 0-7 indicating subclinical symptoms, 8-15 mild symptoms, 16-23 moderate symptoms, 24-31 severe symptoms and 32-40 extreme symptoms.

Response inhibition task 1

Time Frame: up to 1 month after the intervention

Performance in the response inhibition tasks (Flanker test)

Working memory task

Time Frame: up to 1 month after the intervention

Performance in the working memory task as an executive function task

Response inhibition task 2

Time Frame: up to 1 month after the intervention

Performance in the response inhibition tasks (Go/No-Go task)

Secondary Outcomes

  • Beck Depression Questionnaire (BDI-II)(up to 1 month after the intervention)
  • electroencephalogram (EEG) oscillatory power(up to 1 month after the intervention)
  • electroencephalogram (EEG) functional connectivity(up to 1 month after the intervention)
  • Quality of Life Questionnaire (WHOQUL)(up to 1 month after the intervention)

Study Sites (1)

Loading locations...

Similar Trials